Total Payments
$1,761
2024 Payments
$136.79
Companies
25
Transactions
176
Medicare Patients
2,269
Medicare Billing
$187,649
Payment Breakdown by Category
Food & Beverage$1,761 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,761 | 176 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $352.32 | 77 | $0 (2018) |
| Novo Nordisk Inc | $228.03 | 13 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $140.40 | 17 | $0 (2018) |
| ABBVIE INC. | $132.77 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $122.60 | 8 | $0 (2018) |
| Amgen Inc. | $105.16 | 7 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $91.27 | 8 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $66.69 | 5 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $66.27 | 4 | $0 (2018) |
| GlaxoSmithKline, LLC. | $57.82 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $136.79 | 6 | ABBVIE INC. ($91.43) |
| 2023 | $30.36 | 2 | AbbVie Inc. ($16.81) |
| 2022 | $53.65 | 3 | ABBVIE INC. ($24.53) |
| 2021 | $14.01 | 1 | Genentech USA, Inc. ($14.01) |
| 2019 | $12.92 | 1 | Lilly USA, LLC ($12.92) |
| 2018 | $321.63 | 34 | PFIZER INC. ($109.43) |
| 2017 | $1,191 | 129 | PFIZER INC. ($242.89) |
All Payment Transactions
176 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 06/10/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: NEUROSCIENCE | ||||||
| 05/27/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, PEDIARIX | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: VACCINES | ||||||
| 03/18/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: PRIMARY CARE | ||||||
| 10/11/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Virology & Specialty Care | ||||||
| 05/15/2019 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Diabetes | ||||||
| 11/29/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/28/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Endocrinology | ||||||
| 08/27/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/20/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.93 | General |
| 05/16/2018 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: UROLOGY | ||||||
| 05/02/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/13/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/03/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: UROLOGY | ||||||
| 03/28/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/23/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $0.11 | General |
| Category: DERMATOLOGY | ||||||
| 03/16/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/12/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 551 | 981 | $162,386 | $47,938 |
| 2022 | 18 | 638 | 1,131 | $172,917 | $53,828 |
| 2021 | 12 | 567 | 952 | $157,611 | $50,298 |
| 2020 | 14 | 513 | 764 | $122,981 | $35,585 |
Total Patients
2,269
Total Services
3,828
Medicare Billing
$187,649
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 327 | $86,655 | $25,196 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $17,856 | $7,654 | 42.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 31 | $11,036 | $3,200 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 58 | $10,382 | $2,948 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $9,384 | $2,245 | 23.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 34 | 53 | $11,930 | $2,089 | 17.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 108 | 185 | $3,885 | $1,547 | 39.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 31 | 87 | $4,263 | $1,362 | 31.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 33 | 44 | $2,156 | $688.93 | 32.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 46 | $1,840 | $329.92 | 17.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 16 | 18 | $1,303 | $311.58 | 23.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 16 | 16 | $768.00 | $266.72 | 34.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 19 | 29 | $928.00 | $98.89 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 360 | $95,400 | $29,382 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 41 | 41 | $11,439 | $5,014 | 43.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 38 | $13,528 | $4,703 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 74 | $13,246 | $4,094 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $12,240 | $2,842 | 23.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 45 | 54 | $7,020 | $2,204 | 31.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 41 | 80 | $3,920 | $1,305 | 33.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 22 | 27 | $3,375 | $1,218 | 36.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 38 | 39 | $1,911 | $634.75 | 33.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 109 | 214 | $4,494 | $631.05 | 14.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 28 | 56 | $2,240 | $505.99 | 22.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 17 | $493.00 | $448.15 | 90.9% |
About Robert Watson
Robert Watson is a Family Medicine healthcare provider based in Purvis, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669413233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Watson has received a total of $1,761 in payments from pharmaceutical and medical device companies, with $136.79 received in 2024. These payments were reported across 176 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,761).
As a Medicare-enrolled provider, Watson has provided services to 2,269 Medicare beneficiaries, totaling 3,828 services with total Medicare billing of $187,649. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Purvis, MS
- Active Since 06/08/2006
- Last Updated 08/12/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1669413233
Products in Payments
- Victoza (Drug) $146.33
- ENTRESTO (Drug) $140.40
- EUCRISA (Drug) $109.86
- LYRICA (Drug) $107.65
- Prolia (Biological) $105.16
- XIFAXAN (Drug) $80.85
- INVOKANA (Drug) $76.97
- Myrbetriq (Drug) $64.60
- CHANTIX (Drug) $63.23
- VRAYLAR (Drug) $54.70
- VIAGRA (Drug) $53.47
- Amitiza (Drug) $48.96
- UBRELVY (Drug) $47.91
- VESICARE (Drug) $45.23
- ANORO (Drug) $44.85
- Trintellix (Drug) $43.06
- QULIPTA (Drug) $42.52
- Movantik (Drug) $40.44
- JARDIANCE (Drug) $38.53
- PRALUENT (Drug) $27.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Purvis
Stephen Harless, Md, MD
Family Medicine — Payments: $4,900
Family Medicine $4,900
Mr. Bruce Grissom
Family Medicine — Payments: $2,039
Family Medicine $2,039
Christopher Rawls, Md, MD
Family Medicine — Payments: $1,582
Family Medicine $1,582
Michael O'neal, Md, MD
Family Medicine — Payments: $1,138
Family Medicine $1,138
Kaitlyn Warren, Do, DO
Family Medicine — Payments: $68.53
Family Medicine $68.53
John Chmelicek, Md, MD
Family Medicine
Family Medicine